Akynzeo 300-0.5 MG capsules
Ended Awarded
- Contract number
- SPE2DB25FJT24
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,561
Award facts
- Contract value 100% obligated
- $14,561.24 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,561.24 to AmerisourceBergen Drug Corp for AKYNZEO 300-0.5 mg capsules on September 3, 2025, with completion scheduled for September 4, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania, the company's corporate headquarters.
This delivery order represents a routine pharmaceutical procurement supporting federal military healthcare operations. AKYNZEO is a prescription antiemetic medication used primarily to prevent chemotherapy-induced nausea and vomiting. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The award reflects the company's established capability to fulfill federal medical supply requirements through competitive procurement mechanisms and its role as a primary pharmaceutical supplier within the DLA's global medical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJT24?
SPE2DB25FJT24 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 3, 2025.
How much is contract SPE2DB25FJT24 worth?
The government has obligated $14,561 on SPE2DB25FJT24.
Is contract SPE2DB25FJT24 an order under another contract?
Yes. SPE2DB25FJT24 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJT24 competed?
The extent of competition for SPE2DB25FJT24 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award